Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Breast J. 2019 Jun 13;25(5):829–837. doi: 10.1111/tbj.13352

Table 4.

Comparison of stage groups in T1-T2, N0, ER-positive, HER2-negative tumors by TNM alone, TNM+Biomarkers, and TNM+Biomarkers+RS<11

NYULMC 2016–2017 (n=53)
N (%)
MSKCC 2011–2013 (n=232)
N (%)
Stage
Group
TNM TNM+Biomarkers TNM+Biomarker+RS<11 TNM TNM+Biomarkers TNM+Biomarker+RS<11
IA 41 (77.4) 51 (96.2) 53 (100) 214 (92.2) 232 (100) 232 (100)
IB 0 (0) 2 (3.8) 0 (0) 0 (0) 0 (0) 0 (0)
IIA 12 (22.6) 0 (0) 0 (0) 18 (7.8) 0 (0) 0 (0)